Given that the thread has been pretty quiet lately, I thought I would go back to see what was being discussed 12 months ago 07/01/2019 when we were trading at a pre consolidated SP of 3.4c ….
"CEO Marc Voigt said: “We are very excited to be working alongside CYTLIMIC to help evaluate efti as part of an innovative cancer vaccine that has potential as a new therapy.
Efti is generating interest globally. Following the agreements with CYTLIMIC, it is now being evaluated as part of three different combination therapy types: as part of a therapeutic cancer vaccine, as a chemo-immunotherapy and in an IO combination, showing its broad therapeutic potential.”
12 months on it would appear that the company has not been embraced by the market.
Why is it so?
- Forums
- ASX - By Stock
- 2020.....where the rubber hits the road.
Given that the thread has been pretty quiet lately, I thought I...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $458.1M |
Open | High | Low | Value | Volume |
31.5¢ | 32.0¢ | 31.0¢ | $306.8K | 972.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 178587 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 44597 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 178587 | 0.315 |
20 | 548855 | 0.310 |
15 | 203289 | 0.305 |
22 | 459095 | 0.300 |
7 | 125083 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 44597 | 1 |
0.325 | 69516 | 3 |
0.330 | 214747 | 5 |
0.335 | 199036 | 6 |
0.340 | 529176 | 4 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |